Healthcare
Upcoming Earnings
Biotechnology
Medtronic
$91.669876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$91.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.88 (3.24%) Today
+$0.02 (0.02%) After Hours
Why Robinhood?
You can buy or sell Medtronic and other stocks, options, ETFs, and crypto commission-free!
About
Medtronic plc, also called Medtronic, is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. Read More It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Employees
86,368
Headquarters
Dublin, Dublin
Founded
1949
Market Cap
118.99B
Price-Earnings Ratio
25.33
Dividend Yield
2.26
Average Volume
5.37M
High Today
$91.79
Low Today
$90.12
Open Price
$90.96
Volume
5.01M
52 Week High
$100.15
52 Week Low
$81.66
Collections
Healthcare
Upcoming Earnings
Biotechnology
Europe
Europe (Non-UK)
Health
Medical
Medical Devices
News
Seeking Alpha2h
Medtronic plc CEO Omar Ishrak on Q4 2019 Results - Earnings Call Transcript
Medtronic plc (NYSE:MDT) Q4 2019 Earnings Conference Call May 23, 2019 8:00 AM ET Company Participants Ryan Weispfenning - VP, IR Omar Ishrak - Chairman and CEO Karen L. Parkhill - EVP and CFO Hooman Hakami - EVP and President, Diabetes Group Michael J. Coyle - EVP and President, CVG Bob White - EVP and President, MITG Geoffrey S. Martha - EVP and Group President, Restorative Therapies Group Conference Call Participants Bob Hopkins - Bank of America David Lewis - Morgan Stanley Vijay Kumar - Eve...
Reuters5h
Strong surgical instrument sales fuel Medtronic's upbeat forecast
(Reuters) - Medtronic Plc reported quarterly profit ahead of estimates on strong demand for its surgical instruments and forecast better-than-expected 2020 earnings on Thursday, sending shares of the medical device maker up nearly 3%. The company has been building its minimally invasive and robotic surgery device businesses through new launches and acquisitions to ease the impact of rising competition it faces at its top-earning cardiac and vascular unit. There had been growing concerns among investors af...
Yahoo Finance6h
Medtronic Rises 3%
Investing.com - Medtronic (NYSE:MDT) rose by 3.01% to trade at $91.42 by 15:11 (19:11 GMT) on Thursday on the NYSE exchange. The volume of Medtronic shares traded since the start of the session was 9.35M. Medtronic has traded in a range of $90.12 to $91.47 on the day. The stock has traded at $91.4600 at its highest and $86.7600 at its lowest during the past seven days. Scroll to continue with content Ad Related Articles Mastercard Falls 3% Facebook Falls 3% Exclusive: JPMorgan cuts ties with OxyConti...
Price Paid on Robinhood
6% Higher
Right Now
52 Week Low
$81.66
Average Price Paid
$86.40
52 Week High
$100.15
Earnings
$0.94
$1.14
$1.34
$1.54
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
$1.47 per share
Actual
$1.54 per share